Integrated Research Future Growth

Future criteria checks 3/6

Integrated Research se prevé un crecimiento anual de los beneficios y los ingresos de 77.5% y 6.4% respectivamente. Se prevé que el BPA sea de grow en 77.4% al año. Se prevé que la rentabilidad de los fondos propios sea de 13.5% en 3 años.

Key information

66.6%

Earnings growth rate

66.4%

EPS growth rate

Software earnings growth	33.5%
Revenue growth rate	4.5%
Future return on equity	13.0%
Analyst coverage	Low
Last updated	25 Feb 2024

Recent future growth updates

Recent updates

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

Mar 02

Investors Could Be Concerned With Integrated Research's (ASX:IRI) Returns On Capital

Apr 05

Investors Could Be Concerned With Integrated Research's (ASX:IRI) Returns On Capital

Sep 27

Does Integrated Research (ASX:IRI) Have A Healthy Balance Sheet?

Aug 22

Integrated Research (ASX:IRI) Will Will Want To Turn Around Its Return Trends

Jun 14

Integrated Research (ASX:IRI) Seems To Use Debt Quite Sensibly

May 03

We're Watching These Trends At Integrated Research (ASX:IRI)

Mar 08

If You Had Bought Integrated Research's (ASX:IRI) Shares Three Years Ago You Would Be Down 34%

Feb 15

Should You Buy Integrated Research Limited (ASX:IRI) For Its Dividend?

Jan 28

Is There More To The Story Than Integrated Research's (ASX:IRI) Earnings Growth?

Jan 10

Need To Know: This Analyst Just Made A Substantial Cut To Their Integrated Research Limited (ASX:IRI) Estimates

Dec 22

Integrated Research Limited's (ASX:IRI) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Dec 14

Is Integrated Research Limited (ASX:IRI) Potentially Undervalued?

Dec 01

Here's Why Integrated Research (ASX:IRI) Can Manage Its Debt Responsibly

Nov 18

Earnings and Revenue Growth Forecasts

ASX:IRI - Analysts future estimates and past financials data (AUD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2026	81	11	N/A	7	1
6/30/2025	77	12	N/A	7	1
6/30/2024	74	13	N/A	5	1
12/31/2023	72	-21	13	16	N/A
9/30/2023	71	-25	10	15	N/A
6/30/2023	70	-29	6	14	N/A
3/31/2023	69	-13	2	12	N/A
12/31/2022	69	3	-1	9	N/A
9/30/2022	66	2	2	13	N/A
6/30/2022	63	2	5	17	N/A
3/31/2022	70	6	6	18	N/A
12/31/2021	77	10	7	18	N/A
9/30/2021	78	9	8	20	N/A
6/30/2021	78	8	9	21	N/A
3/31/2021	85	10	9	22	N/A
12/31/2020	92	12	9	22	N/A
9/30/2020	101	18	9	23	N/A
6/30/2020	111	24	9	24	N/A
3/31/2020	107	23	10	25	N/A
12/31/2019	104	22	11	25	N/A
9/30/2019	102	22	10	23	N/A
6/30/2019	101	22	9	21	N/A
3/31/2019	98	22	10	22	N/A
12/31/2018	96	22	10	23	N/A
9/30/2018	93	20	10	22	N/A
6/30/2018	91	19	9	21	N/A
3/31/2018	92	20	10	22	N/A
12/31/2017	94	20	12	23	N/A
9/30/2017	92	19	N/A	25	N/A
6/30/2017	91	19	N/A	26	N/A
3/31/2017	90	18	N/A	24	N/A
12/31/2016	88	18	N/A	22	N/A
9/30/2016	87	17	N/A	19	N/A
6/30/2016	85	16	N/A	16	N/A
3/31/2016	80	14	N/A	16	N/A
12/31/2015	76	13	N/A	17	N/A
9/30/2015	73	14	N/A	19	N/A
6/30/2015	70	14	N/A	21	N/A
3/31/2015	65	13	N/A	19	N/A
12/31/2014	61	12	N/A	16	N/A
9/30/2014	57	10	N/A	16	N/A
6/30/2014	53	8	N/A	16	N/A
3/31/2014	53	10	N/A	18	N/A
12/31/2013	54	11	N/A	21	N/A
9/30/2013	51	10	N/A	19	N/A
6/30/2013	49	9	N/A	17	N/A

Analyst Future Growth Forecasts

Ingresos vs. tasa de ahorro: IRI se prevé que sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.2%).

Beneficios frente mercado: IRI se prevé que sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: IRI se espera que sea rentable en los próximos 3 años.

Ingresos vs. Mercado: IRI(4.5% al año) se prevé que crezca más despacio que el mercado de Australian (4.6% al año).

Ingresos de alto crecimiento: IRISe prevé que los ingresos de la empresa (6.4% al año) crezcan más despacio que 20% al año.

Earnings per Share Growth Forecasts

Future Return on Equity

Futura rentabilidad financiera (ROE): IRISe prevé que la Rentabilidad de los fondos propios de la empresa sea baja dentro de 3 años (12.7%).

Discover growth companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Integrated Research Future Growth

Future criteria checks 3/6

Key information

Recent future growth updates

Integrated Research Limited Provides Revenue Guidance for the Full Year 2023

Consensus EPS estimates fall by 22%

Price target increased by 18% to AU$0.65

Price target increased to AU$0.55

Consensus EPS estimates fall by 75%

Price target decreased to AU$1.00

Recent updates

Here's What's Concerning About Integrated Research's (ASX:IRI) Returns On Capital

First half 2024 earnings released: EPS: AU$0.064 (vs AU$0.019 in 1H 2023)

Integrated Research Limited to Report First Half, 2024 Results on Feb 22, 2024

Integrated Research Limited Announces Resignation of James Scott as Director, Effective 30 January 2024

Integrated Research Limited Announces Chief Financial Officer Changes

Integrated Research Limited Provides Revenue Guidance for the Full Year 2023

Is It Time To Consider Buying Integrated Research Limited (ASX:IRI)?

A Look At The Intrinsic Value Of Integrated Research Limited (ASX:IRI)

Integrated Research Limited Announces the Appointment of Michael Hitz as Independent Non-Executive Director

Integrated Research Limited Announces Resignation of Allan Brackin as Director, Effective from 30 September 2023

Is Integrated Research Limited (ASX:IRI) Potentially Undervalued?

Full year 2023 earnings: EPS misses analyst expectations

Integrated Research Limited, Annual General Meeting, Nov 22, 2023

New minor risk - Financial data availability

Consensus EPS estimates fall by 22%

Integrated Research Limited to Report Fiscal Year 2023 Results on Aug 25, 2023

What Is Integrated Research Limited's (ASX:IRI) Share Price Doing?

First half 2023 earnings released: EPS: AU$0.019 (vs AU$0.01 in 1H 2022)

Price target increased by 18% to AU$0.65

Is It Time To Consider Buying Integrated Research Limited (ASX:IRI)?

A Look At The Intrinsic Value Of Integrated Research Limited (ASX:IRI)

Price target increased to AU$0.55

Integrated Research Announces David Purdue to Retire as Company Secretary, Effective 30 September 2022

Now 23% undervalued after recent price drop

Integrated Research Limited, Annual General Meeting, Nov 23, 2022

Full year 2022 earnings released: EPS: AU$0.009 (vs AU$0.046 in FY 2021)

Now 22% undervalued after recent price drop

IR Appoints Rodney Foreman as Senior Vice President, Americas

Integrated Research Announces Executive Changes

Is Integrated Research Limited (ASX:IRI) Potentially Undervalued?

Integrated Research Limited to Report Fiscal Year 2022 Results on Aug 18, 2022

Integrated Research Limited Appoints Katrina Small as Chief People Officer

Now 23% undervalued after recent price drop

Integrated Research Limited Announces the Resignation of Peter Adams as Chief Financial Officer, Effective 31 August 2022

Consensus EPS estimates fall by 75%

Is Integrated Research (ASX:IRI) Using Too Much Debt?

Price target decreased to AU$1.00

Integrated Research Appoints William Witherow as a Company Secretary

Integrated Research Limited Announces Director Appointment

IR's Real-Time Payments Product to Power Organizations' Financial and Business Efficiencies

Investors Could Be Concerned With Integrated Research's (ASX:IRI) Returns On Capital

IR Appoints Stuart Matthewman as Chief Marketing Officer

First half 2022 earnings: EPS exceeds analyst expectations

Consensus EPS estimates fall by 11%

IR Launches Remote Monitoring and Management Solution for Collaboration Spaces

IR Achieves Service Organization Control (SOC) 2 Type I Certification, Affirming its Strong Security Practices and Commitment to Safeguarding Customers and Partners

Price target decreased to AU$1.50

Non-Executive Independent Director recently bought AU$80k worth of stock

Investors Could Be Concerned With Integrated Research's (ASX:IRI) Returns On Capital

Does Integrated Research (ASX:IRI) Have A Healthy Balance Sheet?

Full year 2021 earnings released: EPS AU$0.046 (vs AU$0.14 in FY 2020)

Consensus forecasts updated

Investor sentiment improved over the past week

Integrated Research Limited Announces Earnings Guidance for the Fiscal Year 2021

Chief Commercial Officer Matthew Glasner has left the company

IR Expands Microsoft Teams and Zoom Solution with Extended Cloud Alarms

Consensus EPS estimates fall to AU$0.033

Integrated Research Limited Provides Earnings Guidance for the Second Half and Full Year for Financial Year of 2021

Integrated Research (ASX:IRI) Will Will Want To Turn Around Its Return Trends

Investor sentiment improved over the past week

Integrated Research (ASX:IRI) Seems To Use Debt Quite Sensibly

Independent Chairman Paul Brandling has left the company

We're Watching These Trends At Integrated Research (ASX:IRI)

Non-Executive Independent Director recently bought AU$107k worth of stock

Investor sentiment deteriorated over the past week

New 90-day low: AU$2.36

First half 2021 earnings released: EPS AU$0.001 (vs AU$0.069 in 1H 2020)

Revenue beats expectations

Integrated Research Limited Announces No Interim Dividend for the Half-Year Ended 31 December 2020